Immune Therapeutics, Inc.
Immune Therapeutics, Inc. (IMUN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · IMUN · as of Jun 9, 2026
Key Statistics
Explore Immune Therapeutics, Inc. Data
imun stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
imun competitorsIMUN
BNOEF
CRBKF
FWPAY
HBCNF
IPCIFStock Performance
Full HistoryAbout Immune Therapeutics, Inc.
Immune Therapeutics, Inc. currently conducts no significant business operations. Formerly known as TNI BioTech, Inc., the company adopted its present name in October 2014. Its corporate headquarters a…
what is immune therapeutics, inc. · imun stock overview · immune therapeutics, inc. company profile · who is immune therapeutics, inc. ceo · imun OTC · immune therapeutics, inc. headquarters · immune therapeutics, inc. business segments
About Stock Overview & Key Data
Immune Therapeutics, Inc. (IMUN) is a Healthcare company in the Biotechnology industry, listed on OTC since Aug 20, 2010. As of the latest trading session, IMUN stock price is $0.09, with a market capitalization of $7.8M. The stock has returned -91.14% over the past 12 months and -84.50% year-to-date.
In fiscal year 2022, Immune Therapeutics, Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Immune Therapeutics, Inc. (IMUN) stock price is $0.09. The stock is traded on OTC under the ticker symbol IMUN. The 52-week range is $0.07 – $1.30.